Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

BioNTech Turbocharges COVID-19 Vaccine Development

TheMotleyFool

0 0

The development of a vaccine to prevent COVID-19 infection could progress much faster than expected. On Monday, BioNTech SE (NASDAQ: BNTX) shared more details regarding BNT162, a potential mRNA-based vaccine the German drugmaker has working on in partnership with Pfizer (NYSE: PFE), the University of Pennsylvania, and the Bill and Melinda Gates Foundation.

On Monday, BioNTech announced a new collaboration with Fosun Pharma to develop BNT162 in China. The company formerly known as Shanghai Fosun Pharmaceutical Group will bring its clinical development capabilities in China to the rest of the team working on the BNT162 program called Project Lightspeed.

Image source: Getty Images.

Source Fool.com

Like: 0

BNTX

Teilen